SPONSOR
Guangdong Hengrui Pharmaceutical Co., Ltd
Total Trials
7
Recruiting
7
Phases
Phase 2, Phase 3
Conditions studied: Active Lupus NephritisIPF and PPFAdolescents With Moderate-to-severe Atopic DermatitisCOPDPsoriasisPrimary IgA NephropathyPrimary Membranous Nephropathy
Guangdong Hengrui Pharmaceutical Co., Ltd is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Active Lupus Nephritis, IPF and PPF, Adolescents With Moderate-to-severe Atopic Dermatitis, COPD.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Guangdong Hengrui Pharmaceutical Co., Ltd
How many clinical trials has Guangdong Hengrui Pharmaceutical Co., Ltd sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by Guangdong Hengrui Pharmaceutical Co., Ltd, of which 7 are actively recruiting participants. These trials cover conditions including Active Lupus Nephritis, IPF and PPF, Adolescents With Moderate-to-severe Atopic Dermatitis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Guangdong Hengrui Pharmaceutical Co., Ltd research focus on?
Guangdong Hengrui Pharmaceutical Co., Ltd clinical trials span Active Lupus Nephritis, IPF and PPF, Adolescents With Moderate-to-severe Atopic Dermatitis, COPD, Psoriasis, and additional conditions. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Guangdong Hengrui Pharmaceutical Co., Ltd clinical trial?
To participate in a Guangdong Hengrui Pharmaceutical Co., Ltd trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Guangdong Hengrui Pharmaceutical Co., Ltd trials with current recruitment status updated daily.
Clinical Trials by Guangdong Hengrui Pharmaceutical Co., Ltd
NCT07229742 Phase 2
Recruiting
A Phase II Clinical Study on the Efficacy and Safety of SHR-2173 Injection in the Treatment of Patients With Active Lupus Nephritis
Active Lupus Nephritis
NCT07192939 Phase 2
Recruiting
Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial to Evaluate the Efficacy and Safety of HRS-9813 in Subjects With Pulmonary Fibrosis
IPF and PPF
NCT07309055 Phase 3
Recruiting
A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis
Adolescents With Moderate-to-severe Atopic Dermatitis
NCT07640451 Phase 2
Recruiting
A Clinical Trial to Evaluate the Efficacy and Safety of HRS-9821 Inhalation Suspension in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
COPD
NCT07719530 Phase 2
Recruiting
Phase II Clinical Trial of SHR-1139 Injection in Patients With Psoriasis
Psoriasis
NCT07354932 Phase 2
Recruiting
A Study of SHR-2173 in Participants With Primary IgA Nephropathy
Primary IgA Nephropathy
NCT07289763 Phase 2
Recruiting
Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy
Primary Membranous Nephropathy
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology